GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: BIOD
Accumulate $5

Global Hunter Securities rated BIODEL INC. (NASDAQ: BIOD) to Accumulate with price target $5

Thursday,  May 26, 2011  8:25 AM ET by Lynn Gilbert

Global Hunter Securities rated
BIODEL INC. (NASDAQ: BIOD) to Accumulate with price target $5.

Biodel Inc. (Biodel) is a development-stage specialty pharmaceutical company located in Danbury, Connecticut. The Company is focused on the development and commercialization of treatments for endocrine disorders, such as diabetes and osteoporosis. The Company develops product candidates by applying its formulation technologies to existing drugs in order to improve their therapeutic results. The Company?s initial development efforts are focused on peptide hormones. The Company?s advanced product candidate, VIAject, has been studied in two pivotal Phase III clinical trials for the treatment of patients with Type 1 and Type 2 diabetes. Earlier stage product candidates include VIAtab, a sublingual tablet formulation of insulin and two preclinical product candidates for the treatment of osteoporosis. The Company has developed all of its product candidates utilizing its VIAdel technology that allows the Company to study the interaction between peptide hormones and small molecules.

Global Hunter Securities uses a disciplined quantitative and qualitative approach, our analysts are focused on covering small-cap companies with unique value and above average growth, primarily in the following sectors: Consumer, Energy, Healthcare, Industrial, Services and Technology. Additionally, Global Hunter Securities has analysts specifically focused on Special Situations and International opportunities. Global Hunter Securities' analysts maintain strong relationships and ongoing dialogue with management teams and industry professionals to ensure propitious access to information.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy